Full Text
Cost-Effectiveness Of Idelalisib Plus Rituximab In Chronic Lymphocytic Leukaemia

Abstract

Authors

H Leleu M Blachier S Mealing R Perard C Baujat J Pentel

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×